Develops patient-focused healthcare services to reduce opioid use.
Jun 2026Revenue $39.4M/yrExpenses $508M/yr
No trendCash runway ≈ 5 months from Jun 2026
Figures by year
When will Nakamoto be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $39.4M and expenses $508M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $1.82M | $199M | −$197M |
| Dec 2024 | $2.72M | $6.07M | −$3.35M |
| Dec 2023 | $3.77M | $5.39M | −$1.62M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.